Ext Hair Regrowth Treatment For Men 2%
Product Images NDC 70150-002

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Ext Hair Regrowth Treatment For Men 2% (NDC 70150-002). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ttem, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Box (2019 2percent Male Box V1 As)

Box (2019 2percent Male Box V1 As)
This is a drug facts section for EXT Hair Regrowth Treatment, which contains Minoxidil Topical Solition 2% USP, for use in regrowing hair on the top of the scalp. The product should not be used for front-baldness or receding hairlines. Do not use on children, people under 18 years of age or people with sudden hair loss, a patchy scalp, an infected scalp, painful scalp or a family history of hair loss. The solution must be applied directly on the scalp using a dropper and should be used twice a day. Results are usually seen in 2 to 4 months. The product may have side effects; contact a doctor if one experiences any severe side effects. It is not recommended for pregnant women or women breastfeeding.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.